Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Shortage reports
Actual shortage:
29 (51%)
Anticipated shortage:
0 (0%)
Avoided shortage:
0 (0%)
Resolved:
28 (49%)
57
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
12 (100%)
Reversed:
0 (0%)
12
1 (1%)
1 (3%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAT-ERLOTINIB | 25MG | TABLET | Actual shortage | 2020-12-03 | 2026-03-17 | 129536 |
| NAT-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-02-15 | 2020-10-26 | 75793 |
| NAT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-02-15 | 2020-10-26 | 75799 |
| NAT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-02-02 | 2024-05-10 | 218258 |
| NAT-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2024-04-29 | 2025-07-04 | 226575 |
| NAT-EVEROLIMUS | 5MG | TABLET | Resolved | 2024-11-01 | 2025-07-04 | 241865 |
| NAT-EVEROLIMUS | 10MG | TABLET | Resolved | 2024-11-01 | 2025-07-04 | 241868 |
| NAT-GEFITINIB | 250MG | TABLET | Actual shortage | 2025-04-04 | 2026-03-17 | 254195 |
| NAT-IMATINIB | 100MG | TABLET | Resolved | 2024-08-30 | 2025-07-24 | 236421 |
| NAT-IMATINIB | 400MG | TABLET | Resolved | 2024-08-30 | 2025-07-24 | 236418 |
| NAT-LEVETIRACETAM | 250MG | TABLET | Resolved | 2019-02-15 | 2022-07-01 | 75810 |
| NAT-LEVETIRACETAM | 250MG | TABLET | Actual shortage | 2025-06-25 | 2025-07-03 | 261126 |
| NAT-LEVETIRACETAM | 500MG | TABLET | Resolved | 2018-10-19 | 2020-10-26 | 64878 |
| NAT-LEVETIRACETAM | 500MG | TABLET | Actual shortage | 2025-06-25 | 2025-07-03 | 261129 |
| NAT-LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-04-17 | 2021-10-15 | 81921 |
| NAT-LEVETIRACETAM | 750MG | TABLET | Actual shortage | 2025-04-04 | 2025-07-03 | 254205 |
| NAT-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Actual shortage | 2024-04-29 | 2026-03-17 | 226579 |
| NAT-MONTELUKAST | 10MG | TABLET | Actual shortage | 2025-06-25 | 2026-03-17 | 261132 |
| NAT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Actual shortage | 2024-04-29 | 2026-03-17 | 226582 |
| NAT-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-06-13 | 2025-07-03 | 230400 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAT-DONEPEZIL | 5MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273383 |
| NAT-DONEPEZIL | 10MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273387 |
| NAT-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2026-01-06 | 2026-01-06 | 275276 |
| NAT-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2026-01-06 | 2026-01-06 | 275279 |
| NAT-LEVETIRACETAM | 250MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273390 |
| NAT-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273434 |
| NAT-LEVETIRACETAM | 750MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273437 |
| NAT-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-12-05 | 2025-12-06 | 273440 |
| NAT-QUETIAPINE | 25MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273482 |
| NAT-QUETIAPINE | 100MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273489 |
| NAT-QUETIAPINE | 200MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273496 |
| NAT-QUETIAPINE | 300MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273501 |
Showing 1 to 12 of 12